|
|
Volumn 2, Issue 1, 2000, Pages 14-19
|
|
Does differing metabolism by cytochrome p450 have clinical importance?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTICOAGULANT AGENT;
ANTILIPEMIC AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
CYCLOSPORIN;
CYP3A PROTEIN, HUMAN;
CYTOCHROME P450;
IMMUNOSUPPRESSIVE AGENT;
MIXED FUNCTION OXIDASE;
NICOTINIC ACID;
WARFARIN;
ARTERIOSCLEROSIS;
GENETIC POLYMORPHISM;
HUMAN;
METABOLISM;
REVIEW;
RISK FACTOR;
ANTICOAGULANTS;
ANTILIPEMIC AGENTS;
ARTERIOSCLEROSIS;
CALCIUM CHANNEL BLOCKERS;
CYCLOSPORINE;
CYTOCHROME P-450 ENZYME SYSTEM;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
MIXED FUNCTION OXYGENASES;
NIACIN;
POLYMORPHISM, GENETIC;
RISK FACTORS;
WARFARIN;
|
|
EID: 0033741360
PISSN: 15233804
EISSN: None
Source Type: Journal
DOI: 10.1007/s11883-000-0090-4 Document Type: Review |
|
Times cited : (50)
|
|
References (38)
|
